RecruitingNCT02485847

IRIS Registry: Intelligent Research in Sight Registry


Sponsor

American Academy of Ophthalmology

Enrollment

20,000,000 participants

Start Date

Mar 1, 2014

Study Type

OBSERVATIONAL

Conditions

Summary

The IRIS™ Registry (Intelligent Research in Sight) is the nation's first comprehensive eye disease clinical registry. The American Academy of Ophthalmology is developing it as part of the profession's shared goal of continual improvement in the delivery of eye care.The IRIS Registry will be a centralized system for ophthalmology practices to promote practice innovations and achieve clinical excellence.


Eligibility

Min Age: 6 Months

Inclusion Criteria1

  • Patients who meet the denominator requirements for each measure.

Exclusion Criteria1

  • None

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREOphthalmology

A registry of ophthalmic ambulatory encounters which captures essential data elements for continuous quality improvement efforts, enhanced patient care outcomes, and pay for performance programs.


Locations(1)

American Academy of Opthalmology

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02485847


Related Trials